Nevada High Court Upholds $58 Million Verdict Against Wyeth

LAS VEGAS - The Nevada Supreme Court has upheld a reduced $58 million verdict issued against Wyeth Pharmaceuticals in a suit involving its hormone replacement drugs Prempro and Premarin, ruling that the evidence supports the compensatory and punitive damages awarded. Rowatt, et al.[McCreary] v. Wyeth Pharmaceuticals, et al., No. CV04-01699 (Nev. Dist. Ct., Washoe Cty. ).

On Nov. 24, the court ruled that the trial court did not abuse its discretion in denying Wyeth's motion for a new trial because the jury properly found that Wyeth was negligent in failing to conduct appropriate studies on breast cancer and acted with …